Medicaid Overpayment Recovery via Statistical Sampling and Extrapolation

Colorado Governor signed HB1412 into law, authorizing the Department of Health Care and Financing to use statistical sampling and extrapolation methods to recover Medicaid overpayments from providers. The bill includes appropriation provisions for implementation. Healthcare providers participating in Medicaid should prepare for potential overpayment recovery audits using these new statistical methods.

Colorado HB1411 Expands Health Coverage for Immigrants

Colorado Governor signed HB1411 into law on April 6, 2026, expanding the Cover All Coloradans Program to provide health insurance benefits to certain low-income individuals ineligible for medical assistance due to immigration status. The bill makes and reduces appropriations to support the expanded coverage.

2026-27 Long Appropriations Bill

Colorado Governor signed HB1410, the 2026-27 Long Appropriations Bill, into law on April 6, 2026. The bill authorizes funding for executive, legislative, and judicial departments and state agencies for the fiscal year beginning July 1, 2026. This is the state's primary budget authorization legislation covering all major departments and institutions.

Bond Hearing Officer Process Modification for Weekend Bonds

Colorado Governor signed SB26-037 into law on April 2, 2026, modifying the bond hearing officer process to allow local elected judicial officers to set weekend bonds. The bill passed both chambers unanimously (Senate 33-0, House 59-0) after committee review and amendment. This change affects criminal court operations and bond-setting procedures statewide in Colorado.

Vulnerable Adult Financial Exploitation Banking Protection

Colorado HB1110 was signed into law on April 6, 2026, creating protections for vulnerable adults from financial exploitation in relation to financial institutions. The bill passed the House (44-18) and Senate after amendments, with sponsorship from both Democratic and Republican legislators. Financial institutions in Colorado must now implement measures to identify and report suspected financial exploitation of vulnerable adults.

Erbe USA Flexible Cryoprobe Recall - Rupture Risk

FDA issued a Class I recall for Erbe USA Inc's Flexible Cryoprobe (REF: 20402-410) due to reports of probes rupturing or bursting during activation, posing serious injury risk to patients during surgical procedures. The recall affects all units distributed nationwide including Puerto Rico. Healthcare facilities with this device must immediately cease use and contact Erbe USA for return instructions.

Philips Trilogy Evo Class I recall, tidal volume discrepancy

Philips Trilogy Evo Class I recall, tidal volume discrepancy

Merit Medical DuraMax Hemodialysis Catheter Class I Recall

FDA issued a Class I recall for Merit Medical Systems DuraMax Chronic Hemodialysis Catheter due to a design defect in the 16F dual-valved splittable sheath introducer. The defect may cause the sheath to fail to split as intended during procedures, potentially resulting in hemorrhage, foreign bodies left in patients, and procedure delays. The recall affects multiple product reference numbers distributed nationwide across 25+ states.

Handy Solutions Heating Pad Recall - Burn Hazard

The FDA issued a Class I recall for 847 Handy Solutions Neck & Shoulders Heating Pads (Number: 25607) manufactured by Ninbo Unico Products Co., Ltd and distributed by Navajo Manufacturing Company. The recall was initiated due to a burn hazard where folding the pad during use causes power density to increase beyond the high limit device's sensing capability, preventing automatic power termination. Distribution was nationwide across California, Mississippi, Florida, Indiana, Louisiana, Virginia, and Texas.

Merit Medical BioFlo Recall - Class I Design Defect

FDA issued Class I recall Z-1579-2026 for Merit Medical BioFlo DuraMax Catheter (16F dual-valved splittable sheath introducer) due to a design defect that may prevent proper splitting, potentially causing hemorrhage, foreign bodies, and procedure delays. The recall affects multiple product codes and is ongoing. US nationwide distribution confirmed to healthcare facilities.